Xconomy National

Archives

by in

Entry	Author	Date	Location
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More	Erin Kutz	01/13/12	Boston
Civitas Charts Positive Data on Inhaled Parkinson’s Drug	Arlene Weintraub	01/06/12	Boston
Infinity, Idera, Civitas, & More Boston-Area Life Sciences Headlines	Erin Kutz	12/02/11	Boston
Rib-X, Skyhook, Michael J. Fox Foundation & More Boston-Area Deals News	Erin Kutz	11/30/11	Boston
Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug	Luke Timmerman	11/29/11	Boston
23andMe Identifies Possible Protective Gene Against Parkinson’s Disease	Bruce V. Bigelow	10/25/11	San Diego
NIH Awards $2.1M grant for Parkinson’s Research at Wayne State University	Sarah Schmid	09/26/11	Detroit
Neurologix Forges Ahead on Gene Therapy Treatment for Parkinson’s	Arlene Weintraub	06/23/11	New York
NeuroHealing Repurposes Drugs, Resulting in Potential New Remedies For CNS Disorders	Arlene Weintraub	06/02/11	Boston
23andMe Brings Down the Price of Consumer Genetic Tests, Builds Up Relations With Big Pharma	Luke Timmerman	05/24/11	San Francisco
Prexa Pulls In $7M From Advent, Shire	Erin Kutz	05/11/11	Boston
Acadia Raises $15M	Bruce V. Bigelow	01/10/11	San Diego
Alkermes Finds New Home For Inhaled Drug-Delivery Tech with Civitas Spinout	Ryan McBride	01/10/11	Boston
Boston Scientific Buys Intelect	Ryan McBride	01/05/11	Boston
Biogen Idec Buys Drug Rights from Neurimmune for $32.5M	Ryan McBride	12/21/10	Boston
Ceregene Adds $11.5M	Luke Timmerman	11/11/10	San Diego
Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News	Luke Timmerman	10/15/10	San Francisco
Synosia Raises $30M, Strikes Deal With UCB Worth Up to $725M for Parkinson’s Drugs	Luke Timmerman	10/12/10	San Francisco
Intrigue, Fraud Surround Death of Biotech Angel Investor, Neurocrine Biosciences Signs Two Big Deals, Regulus Therapeutics Signs Sanofi-Aventis Deal, & More San Diego Life Sciences News	Bruce V. Bigelow	06/24/10	San Diego
Ceregene Gets $2.5M From Fox Foundation	Bruce V. Bigelow	06/23/10	San Diego
San Diego’s Neurocrine Biosciences Scores Second Big Deal in Two Days	Denise Gellene	06/18/10	San Diego
FoldRx Pharma Finds $29M, Plans to Seek Approval of First Drug in 2010	Ryan McBride	06/15/10	Boston
Avalon Raising New Fund, Althea Technologies Gets Altus Assets, Trancon Pharmaceuticals Nabs Financing, & More San Diego Life Sciences News	Denise Gellene	05/06/10	San Diego
Link Medicine Ups Third Round to $45M, Taking Aim at Alzheimer’s and Parkinson’s	Ryan McBride	05/04/10	Boston
Acadia Pharma Shares Crash After Lead Parkinson’s Drug Fails in Trial	Ryan McBride	09/01/09	San Diego
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say	Luke Timmerman	08/26/09	Seattle
Acadia Files Shelf Registration	Denise Gellene	08/10/09	San Diego
Isis Prepares Novel Treatment for Lou Gehrig’s Disease, BrainCells Is Encouraged by New Drug for Depression, Inovio Raises $30M, & More San Diego Life Sciences News	Bruce V. Bigelow	08/06/09	San Diego
No More Tears: Avanir Investors Await Trial Results on Emotional Outburst Drug	Denise Gellene	07/23/09	San Diego
San Diego’s Acadia Awaits Parkinson’s Trial Results (and a Chance to Prove Naysayers Wrong)	Denise Gellene	05/19/09	San Diego
Page 1 of 2	next page »